# Efficacy and Safety of Fluticasone Propionate Nebulized Suspension for Wheezing Diseases in Infants Aged 0-24 Months

> **NCT07675252** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine** · enrollment: 240 (estimated)

## Conditions studied

- Acute Wheezing Disorders in Infants Aged 0 to 24 Months

## Interventions

- **DRUG:** Fluticasone Propionate Nebulization
- **DRUG:** Budesonide Nebulization

## Key facts

- **NCT ID:** NCT07675252
- **Lead sponsor:** Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-01
- **Primary completion:** 2027-05-31
- **Final completion:** 2027-06-30
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2026-06-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07675252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07675252, "Efficacy and Safety of Fluticasone Propionate Nebulized Suspension for Wheezing Diseases in Infants Aged 0-24 Months". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07675252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*